MoneyWorks4Me

Lupin informs about press release

15 Sep 2021 Evaluate

Lupin has informed that it attached a press release as regards launch of the authorized generic version of Duexis® (ibuprofen and famotidine) Tablets, 800 mg/ 26.6 mg, of Horizon Medicines LLC. Considered this as a disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..